A detailed history of Matrix Private Capital Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Matrix Private Capital Group LLC holds 1,880 shares of ABBV stock, worth $343,908. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,880
Previous 2,130 11.74%
Holding current value
$343,908
Previous $365,000 1.64%
% of portfolio
0.22%
Previous 0.23%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $40,960 - $49,832
-250 Reduced 11.74%
1,880 $371,000
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $4,488 - $5,242
29 Added 1.38%
2,130 $365,000
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $5,035 - $6,266
-38 Reduced 1.78%
2,101 $283,000
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $15,907 - $18,319
-110 Reduced 4.89%
2,139 $340,000
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $27,523 - $33,008
-199 Reduced 8.13%
2,249 $363,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $82,136 - $94,205
-612 Reduced 20.0%
2,448 $329,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $10,734 - $13,646
78 Added 2.62%
3,060 $469,000
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $18,873 - $23,416
143 Added 5.04%
2,982 $483,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $73,804 - $93,383
687 Added 31.92%
2,839 $384,000
Q3 2021

Feb 22, 2022

SELL
$106.4 - $120.78 $23,514 - $26,692
-221 Reduced 9.31%
2,152 $232,000
Q1 2021

Feb 22, 2022

BUY
$102.3 - $112.62 $51,559 - $56,760
504 Added 26.97%
2,373 $257,000
Q4 2020

Feb 22, 2022

BUY
$80.49 - $108.67 $150,435 - $203,104
1,869 New
1,869 $200,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $323B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Matrix Private Capital Group LLC Portfolio

Follow Matrix Private Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Private Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Private Capital Group LLC with notifications on news.